Sign up for free insights newsletter
00

JW Pharmaceutical Corp

001067KO

Need professional-grade analysis? Visit stockanalysis.com

₩55,900.00
+0.00%
End of day
Market Cap

$1.28T

P/E Ratio

20.87

Employees

1,048

Dividend Yield

1.16%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-2.230.39-2.11-1.26-0.55-0.09-0.80
Calmar1.31-2.93-1.44-0.46-0.03-0.76
Sharpe-1.330.22-1.50-0.81-0.37-0.06-0.54
Omega0.751.070.690.830.941.020.90
Martin-18.683.80-5.31-3.15-0.88-0.05-2.21
Ulcer0.480.584.274.568.1132.6311.82

JW Pharmaceutical Corp (001067) Price Performance

JW Pharmaceutical Corp (001067) trades on KO in KRW. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at KRW55900.00.

Over the past year, 001067 has traded between a low of KRW55350.00 and a high of KRW65600.00. The stock has lost 7.1% over this period. It is currently 14.8% below its 52-week high.

JW Pharmaceutical Corp has a market capitalization of $1.28T, with a price-to-earnings ratio of 20.87 and a dividend yield of 1.16%.

About JW Pharmaceutical Corp

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.

Company Info

Exchange
KO
Currency
KRW

Financial Metrics

Revenue (TTM)
$775.30B
EBITDA
$106.62B
Profit Margin
7.93%
EPS (TTM)
N/A
Book Value
369369.60

Technical Indicators

52 Week High
₩65,600.00
52 Week Low
₩54,900.00
50 Day MA
₩57,734.00
200 Day MA
₩60,128.00
Beta
1.18

Valuation

Trailing P/E
20.87
Forward P/E
N/A
Price/Sales
1.66
Price/Book
3.54
Enterprise Value
$1.29T